<DOC>
	<DOCNO>NCT02848430</DOCNO>
	<brief_summary>Human safety study carry test whether hop botanical dietary supplement use peri- post-menopausal woman safe use Food Drug Administration ( FDA ) -approved drug . To test , hop dietary supplement ( previously test woman University Illinois Chicago without harmful effect ) give four select FDA-approved drug determine hop supplement increase decrease medication absorb , metabolize excreted human body . Preclinical study predict hop supplement might affect metabolism break probe drug .</brief_summary>
	<brief_title>Hop Botanical Dietary Supplements - Metabolism Safety Women</brief_title>
	<detailed_description>At start study , subject administer low dos mixture four FDA-approved drug ( caffeine , tolbutamide , dextromethorphan , alprazolam ) , serial blood sample draw analyzed concentration drug time . Afterwards , participant take hop dietary supplement twice daily 14 day allow potential inhibition induction drug metabolize enzyme transporter . Thereafter , drug take obtain second measure drug concentration blood time . Changes concentration-time curve value probe drug obtain ingestion supplement would indicate metabolism probe drug impact hop dietary supplement .</detailed_description>
	<criteria>healthy peri postmenopausal woman age 40 75 nonsmoker nosignificant medical condition assess subjectreported medical history , physical examination blood urine chemistry screen medical condition require chronic use medication know allergy hypersensitivity caffeine , dextromethorphan , sulfonylurea ( tolbutamide ) , benzodiazepine , red clover , licorice , hop positive pregnancy test use hormone therapy within 8 week study initiation oral agent , 4 week transdermal topical agent use caffeine product 7 day study participation study use citrus product 7 day study participation study use prescription nonprescription medicine within 2 week prior study initiation study chronic disease , inflammatory bowel disease , could alter absorption metabolism probe substrates unwillingness comply study requirement current participation another clinical trial CYP2D6 deficiency base phenotyping screen smoker hop intake ( whether botanical dietary supplement beer ) within previous two week study use dietary supplement within last 2 week prior study initiation study obesity ( define &gt; 33 BMI ) alcohol drug abuse chronic disease inflammatory bowel disease diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Humulus lupulus</keyword>
</DOC>